Cargando…
European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)
INTRODUCTION: No guideline currently exists on how to detect or document haemolysis, icterus or lipemia (HIL) in blood samples, nor on subsequent use of this information. The EFLM WG-PRE has performed a survey for assessing current practices of European laboratories in HIL monitoring. This second pa...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Croatian Society of Medical Biochemistry and Laboratory Medicine
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559623/ https://www.ncbi.nlm.nih.gov/pubmed/31223259 http://dx.doi.org/10.11613/BM.2019.020705 |
_version_ | 1783425831074267136 |
---|---|
author | Cadamuro, Janne Lippi, Giuseppe von Meyer, Alexander Ibarz, Mercedes van Dongen, Edmee Cornes, Michael Nybo, Mads Vermeersch, Pieter Grankvist, Kjell Guimaraes, Joao Tiago Kristensen, Gunn B.B. de la Salle, Barbara Simundic, Ana-Maria |
author_facet | Cadamuro, Janne Lippi, Giuseppe von Meyer, Alexander Ibarz, Mercedes van Dongen, Edmee Cornes, Michael Nybo, Mads Vermeersch, Pieter Grankvist, Kjell Guimaraes, Joao Tiago Kristensen, Gunn B.B. de la Salle, Barbara Simundic, Ana-Maria |
author_sort | Cadamuro, Janne |
collection | PubMed |
description | INTRODUCTION: No guideline currently exists on how to detect or document haemolysis, icterus or lipemia (HIL) in blood samples, nor on subsequent use of this information. The EFLM WG-PRE has performed a survey for assessing current practices of European laboratories in HIL monitoring. This second part of two coherent articles is focused on HIL. MATERIALS AND METHODS: An online survey, containing 39 questions on preanalytical issues, was disseminated among EFLM member countries. Seventeen questions exclusively focused on assessment, management and follow-up actions of HIL in routine blood samples. RESULTS: Overall, 1405 valid responses from 37 countries were received. A total of 1160 (86%) of all responders stating to analyse blood samples - monitored HIL. HIL was mostly checked in clinical chemistry samples and less frequently in those received for coagulation, therapeutic drug monitoring and serology/infectious disease testing. HIL detection by automatic HIL indices or visual inspection, along with haemolysis cut-offs definition, varied widely among responders. A quarter of responders performing automated HIL checks used internal quality controls. In haemolytic/icteric/lipemic samples, most responders (70%) only rejected HIL-sensitive parameters, whilst about 20% released all test results with general comments. Other responders did not analysed but rejected the entire sample, while some released all tests, without comments. Overall, 26% responders who monitored HIL were using this information for monitoring phlebotomy or sample transport quality. CONCLUSION: Strategies for monitoring and treating haemolytic, icteric or lipemic samples are quite heterogeneous in Europe. The WG-PRE will use these insights for developing and providing recommendations aimed at harmonizing strategies across Europe. |
format | Online Article Text |
id | pubmed-6559623 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Croatian Society of Medical Biochemistry and Laboratory Medicine |
record_format | MEDLINE/PubMed |
spelling | pubmed-65596232019-06-20 European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) Cadamuro, Janne Lippi, Giuseppe von Meyer, Alexander Ibarz, Mercedes van Dongen, Edmee Cornes, Michael Nybo, Mads Vermeersch, Pieter Grankvist, Kjell Guimaraes, Joao Tiago Kristensen, Gunn B.B. de la Salle, Barbara Simundic, Ana-Maria Biochem Med (Zagreb) Original Articles INTRODUCTION: No guideline currently exists on how to detect or document haemolysis, icterus or lipemia (HIL) in blood samples, nor on subsequent use of this information. The EFLM WG-PRE has performed a survey for assessing current practices of European laboratories in HIL monitoring. This second part of two coherent articles is focused on HIL. MATERIALS AND METHODS: An online survey, containing 39 questions on preanalytical issues, was disseminated among EFLM member countries. Seventeen questions exclusively focused on assessment, management and follow-up actions of HIL in routine blood samples. RESULTS: Overall, 1405 valid responses from 37 countries were received. A total of 1160 (86%) of all responders stating to analyse blood samples - monitored HIL. HIL was mostly checked in clinical chemistry samples and less frequently in those received for coagulation, therapeutic drug monitoring and serology/infectious disease testing. HIL detection by automatic HIL indices or visual inspection, along with haemolysis cut-offs definition, varied widely among responders. A quarter of responders performing automated HIL checks used internal quality controls. In haemolytic/icteric/lipemic samples, most responders (70%) only rejected HIL-sensitive parameters, whilst about 20% released all test results with general comments. Other responders did not analysed but rejected the entire sample, while some released all tests, without comments. Overall, 26% responders who monitored HIL were using this information for monitoring phlebotomy or sample transport quality. CONCLUSION: Strategies for monitoring and treating haemolytic, icteric or lipemic samples are quite heterogeneous in Europe. The WG-PRE will use these insights for developing and providing recommendations aimed at harmonizing strategies across Europe. Croatian Society of Medical Biochemistry and Laboratory Medicine 2019-06-15 2019-06-15 /pmc/articles/PMC6559623/ /pubmed/31223259 http://dx.doi.org/10.11613/BM.2019.020705 Text en ©Croatian Society of Medical Biochemistry and Laboratory Medicine. This is an Open Access article distributed under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles Cadamuro, Janne Lippi, Giuseppe von Meyer, Alexander Ibarz, Mercedes van Dongen, Edmee Cornes, Michael Nybo, Mads Vermeersch, Pieter Grankvist, Kjell Guimaraes, Joao Tiago Kristensen, Gunn B.B. de la Salle, Barbara Simundic, Ana-Maria European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) |
title | European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) |
title_full | European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) |
title_fullStr | European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) |
title_full_unstemmed | European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) |
title_short | European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) |
title_sort | european survey on preanalytical sample handling – part 2: practices of european laboratories on monitoring and processing haemolytic, icteric and lipemic samples. on behalf of the european federation of clinical chemistry and laboratory medicine (eflm) working group for the preanalytical phase (wg-pre) |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559623/ https://www.ncbi.nlm.nih.gov/pubmed/31223259 http://dx.doi.org/10.11613/BM.2019.020705 |
work_keys_str_mv | AT cadamurojanne europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT lippigiuseppe europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT vonmeyeralexander europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT ibarzmercedes europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT vandongenedmee europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT cornesmichael europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT nybomads europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT vermeerschpieter europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT grankvistkjell europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT guimaraesjoaotiago europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT kristensengunnbb europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT delasallebarbara europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre AT simundicanamaria europeansurveyonpreanalyticalsamplehandlingpart2practicesofeuropeanlaboratoriesonmonitoringandprocessinghaemolyticictericandlipemicsamplesonbehalfoftheeuropeanfederationofclinicalchemistryandlaboratorymedicineeflmworkinggroupforthepreanalyticalphasewgpre |